McKinsey senior partners: America’s growth strategy demands a health reset

Despite spending more on healthcare than any other country, Americans are on track to spend more years in poor health in 2050 than they did in 2000 if current trends hold.

That gap – between what we spend and how healthy we are – should concern anyone who cares about the country’s future.

Longer lives are a gift.

But longer lives marked by chronic illness strain families, weaken the workforce, and raise public costs.

There is another path, and the US already has the tools in hand.

New analysis from the McKinsey Health Institute finds that scaling proven, cost-effective interventions – not speculative breakthroughs – could add 19 million years of healthy life by 2050 and roughly $3.2 trillion to the U.S. economy.

These figures are not a “healthcare savings” story.

They reflect a fundamental expansion of productive capacity: more Americans participating fully in the workforce, fewer workers constrained by illness, and fewer careers cut short by caregiving obligations.

Hospitals, specialists, and cutting-edge therapies in the US are among the world’s best.

However, expertise in treating disease has not translated into sustained gains in healthy life expectancy.

The US system is less consistent at preventing illness, detecting it early, or slowing its progression.

The result is a system that excels once patients are sick, but too often intervenes late — after costs have mounted and options have narrowed.

When disease sidelines working-age adults, labor-force participation softens and output per worker falls.

Chronic, untreated, or poorly managed conditions suppress productivity through both absenteeism and presenteeism.